Since morphine has been shown to be a P-gp substrate [34] and is considered to be the “opiate of choice” for pain treatment of moderate to severe pain resulting from pathophysiological conditions such as cancer [35], we chose [3H]morphine as the test substrate for our in situ brain perfusion studies. This evidence concerns the gene PGP and cancer.